TruthArchive.ai - Related Video Feed

The speaker discusses the use of mRNA in food and mentions a presentation about genetically engineering mosquitoes to deliver vaccines through mosquito bites. They mention that the Gates Foundation is funding this research, although they don't have proof of its viability. The speaker clarifies that they are not suggesting that the mosquitoes are currently injecting anyone with anything, but they have evidence that efforts are being made to enable mosquito injections.

Speaker 0 suggests solving the problem by spraying hotspots in a specific area to test its effectiveness. Speaker 1 mentions that the district commissioner informs people about a new medicine that kills mosquitoes and other insects. Some Africans are skeptical, fearing poisoning or witchcraft. To prove its safety, the entomologist eats porridge sprayed with the solution, but the audience remains unconvinced. The chief spokesman objects, believing the medicine is a dangerous poison that could harm the entire tribe.

The discussion centers on gain-of-function (GoF) research, its regulation, and the motivations behind it. The first speaker notes the administration’s goal to end GoF research and asks where that stands. The second speaker says progress has been made, and the White House is working on a formal policy. He then defines the issue in stages: what GoF research is, why someone would do it, and how to regulate it to prevent dangerous projects that could catastrophically harm human populations. He clarifies that GoF research is not inherently bad, but dangerous GoF research is. He gives an insulin example: creating bacteria to produce insulin is a legitimate GoF that benefits diabetics. In contrast, taking a virus from bat caves, bringing it to a lab in a densely populated city with weak biosafety, and manipulating it to be more transmissible among humans is a dangerous GoF that should not be supported. The administration’s policy aims to prevent such dangerous work entirely, and the President signed an executive order in April or May endorsing this policy. Next, he discusses implementation: how to create incentives to ensure this research does not recur. He explains that the utopian idea behind such research was to prevent all pandemics by collecting viruses from wild places, testing their potential to infect humans by increasing their pathogenicity, and then preparing countermeasures in advance (vaccines, antivirals) and stockpiling them, even though those countermeasures would not have been tested against humans yet. If a virus did leap to humans, the foreseen countermeasures might prove ineffective because evolution is unpredictable. This “triage” approach—identifying pathogens most likely to leap and preemptively preparing against them—was the rationale for dangerous GoF work, a rationale he characterizes as flawed. He notes that many scientists considered this an effort to do bioweapons research under the guise of safety and defense. The work is dual-use. The U.S. is a signatory to the Biological Weapons Convention and does not conduct offensive bio-weapons research, but other countries might. The discussion highlights that the GoF research discussed during the pandemic can backfire and may not align with true biodefense, since countermeasures might not match whatever pathogen actually emerges. The speaker concludes that this agenda—pursuing GoF to prevent pandemics—has drawn substantial support from parts of the Western world and other countries for about two and a half decades, but he implies it is not deserving of continuation.

CRISPR, a lab technique, can alter mosquito DNA to decrease their population or prevent them from carrying parasites. Discussions are underway with African countries to determine the necessary tests and trials before implementing this technique. Although it will take several years to obtain country approvals, the potential to reduce mosquito populations and eliminate malaria locally is promising. The speaker even brought some mosquitoes to the auditorium to provide firsthand experience. They emphasize that it is unfair for only poor people to face this issue.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. By introducing Wolbachia bacteria into the mosquitoes, their ability to transmit diseases like dengue is stopped. The process involves releasing Wolbachia-infected mosquitoes into the wild population through mating. The factory houses mosquito eggs, larvae, and pupae, which are sorted by sex to manipulate the sex ratio. The mosquitoes are fed blood and then either packaged as eggs or released as adults into the field. With over half the world's population at risk of these diseases, the goal is to scale and deliver this solution to communities in need.

Speaker 0 accuses Bill Gates of releasing billions of genetically modified mosquitoes and says Gates talked about using mosquitoes to deliver an mRNA vaccine so people wouldn’t know what was happening. The speaker asserts that the EPA approved this, and claims the mosquitoes are genetically modified to get rid of malaria. The speaker questions Gates’ motives, asserting that Gates has never done anything to help humanity or the 13 families, and insisting Gates cares about pushing vaccines to control the population, including “by pushing a button and billions of people just drop where they’re standing,” and by controlling the rest of the population. The speaker says the issue isn’t avoiding shots, but that vaccines are being put into everything people are exposed to—food, water, air—and now into mosquitoes so they can inject people. The speaker claims that everyone on the planet currently has the mRNA spike protein in them and urges detoxing from it and following a detox protocol until the 13 families and their puppets are removed from power. The speaker encourages watching a video about Gates and the mosquitoes. Speaker 1 reframes the issue by saying Bill Gates is turning the world into a banquet for genetically engineered mosquitoes, and that this is being done with EPA approval. The claim is that the people were not consulted, and some are unhappy about it. The executive director of the Florida Keys Environmental Coalition is quoted as saying the EPA forgot its middle name, Protection, and that the EPA has not shown any investigation proving that this experimental insect won’t create infinitely more problems than it will solve. Speaker 2 adds that no independent scientists have corroborated anything claimed by the vendor, and describes the mosquitoes as genetically engineered, blood-sucking insects carrying deadly diseases being released into neighborhoods. Speaker 0 reiterates that this is “crazy stuff” but true, noting Gates talked about it in speeches two years ago and that it was launched into the population, with Florida being bombarded.

Hi. I'm Scott O'Neill here in Medellin, Colombia today, and I'm at the world's biggest mosquito factory for the World Mosquito Program. We're making in here 30,000,000 mosquitoes a week. We've been able to bring the solution of Wolbachia mosquitoes to the city. When this bacteria called Wolbachia gets introduced into the mosquito, it stops their ability to transmit dengue. We release mosquitoes that have Wolbachia, and then they go and mate, and Wolbachia gets passed into the wild mosquito population. If we're going to control these diseases in all the tropical cities of the world, it's gonna require a lot of mosquitoes. The mosquito life cycle starts with the egg, and in this room, we've got a lot of eggs. Each one of these strips, these tiny black dots are up to 10,000 mosquito eggs.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. They are using Wolbachia bacteria to stop the transmission of diseases like dengue, Zika, and chikungunya. The factory starts with mosquito eggs, which hatch into larvae and then pupae. The males and females are sorted, with more females being desired. The adult mosquitoes are either packaged as eggs in gelatin capsules or released directly into the field. The goal is to scale this solution and deliver it to communities worldwide that are affected by these diseases.

The speaker states that mRNA in food is a critical issue, but also highlights the potential for transgenic mosquitoes to deliver vaccines via saliva. They reference a presentation about producing a transgenic mosquito as a "flying syringe" to deliver protective vaccines. The speaker claims the Gates Foundation is funding genetic engineering of mosquitoes with the intention of using mosquito bites for vaccination. While they don't have definitive proof of its viability, they assert that this research is underway. The speaker clarifies they are not claiming current mosquitoes are injecting people with anything. However, they state they have indisputable evidence that efforts are being made to enable mosquitoes to inject people with substances in the future.

There is a technique called CRISPR in the lab that can manipulate mosquito DNA to reduce their population or eliminate the disease they carry. Discussions are ongoing with African countries to determine the necessary tests and trials before implementing this solution. However, obtaining country approvals will take several years. Despite the time frame, the potential of reducing mosquito population and eradicating the disease locally makes this approach highly promising.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. They are using Wolbachia bacteria to prevent the transmission of diseases like dengue, Zika, and chikungunya. The process involves introducing Wolbachia into the mosquitoes, which then pass it on to the wild mosquito population through mating. The factory houses mosquito eggs, larvae, and pupae, which are sorted by sex to manipulate the sex ratio in the cages. The mosquitoes are fed blood and can be released into the field either as eggs or as adults. The program aims to scale and deliver this solution to communities worldwide.

We are in Medellin, Colombia at the world's largest mosquito factory for the World Mosquito Program. We produce 30 million mosquitoes a week to combat diseases like dengue and Zika by introducing Wolbachia bacteria into the mosquito population. The process starts with eggs, then larvae, pupae, and finally adult mosquitoes. We sort males from females to control the sex ratio. The mosquitoes are fed blood and then released into the field to mate and spread Wolbachia.

I'm Scott O'Neill in Medellin, Colombia at the world's largest mosquito factory for the World Mosquito Program. We produce 30 million Wolbachia mosquitoes weekly to combat diseases like dengue. The Wolbachia bacteria stops mosquitoes from transmitting dengue. We breed mosquitoes from eggs to adults, sorting males and females to control the sex ratio. The females are released into the field after feeding on blood. Our goal is to reduce mosquito-borne diseases in tropical cities worldwide.

A billion genetically modified mosquitoes are being released in the Florida Keys to combat diseases like dengue, yellow fever, and Zika. This is the first time such mosquitoes are being released in the US. The British biotech company, Oxitec, obtained permission from the EPA to release them across 6,000 acres in Florida and Texas. However, a 2019 Yale University study warned that this plan could have unintended consequences. It suggested that the release of these mosquitoes could lead to the creation of hybrid mosquito babies that are more resistant to insecticides, potentially worsening the spread of diseases. The potential risks raise concerns about the success of this initiative.

Genetically modified mosquitoes approved for release in the US mate with females, causing their offspring to die. The program aims to vaccinate people without consent by using mosquitoes as "flying syringes." Concerns arise from the use of partially true narratives to introduce GMO insects, with potential implications for involuntary vaccinations.

Malaria's impact is greatly underestimated, with over 200 million people suffering from it at any given time. This hinders economic progress in affected areas. Malaria is transmitted by mosquitoes, which I have brought here for you to experience. We will release them in the auditorium so everyone can understand. These mosquitoes are not infected.

Researchers are conducting research on injecting mosquitoes with vaccines, which the speakers find concerning. They question the containment of these mosquitoes once released and express worries about the potential negative consequences, citing previous instances of invasive species. The modified mosquitoes have already been released in Florida, and the speakers mention the occurrence of malaria cases in Florida and Texas. They express concern about the decision-making process and the potential widespread impact of these mosquitoes. They criticize the idea of blindly trusting the researchers and highlight the need for public discussion and political involvement. The speakers liken the situation to a horror movie plot.

Malaria eradication is challenging, but gene drive technology could change the genetics of mosquitoes to help achieve this goal. Mosquitoes can be genetically modified to act as "flying syringes" that deliver malaria vaccines when they bite humans. However, there are concerns about the potential risks of spreading malaria and the ethical implications of genetically modifying mosquitoes without informed consent. Despite these concerns, the development of new tools and technologies is crucial for malaria eradication.

For example, there's more money put into baldness drugs than are put into malaria. Now baldness is it's terrible thing. And rich men are afflicted. And so that's why that priority has been set. But malaria, even the million deaths a year caused by malaria, greatly understate its impact. Over two hundred million people at any one time are suffering from it. It means that you can't get the economies in these areas going because there's just it holds things back so much. Malaria is, of course, transmitted by mosquitoes. I brought some here so you could experience this. We'll let those roam around the auditorium a little bit there. There's no reason only poor people should have have the experience. Those mosquitoes are not not infect

In 1956, the US military released Aedes aegypti mosquitoes infected with the malaria virus in Savannah, Georgia as part of Operation Big Buzz. Now, the military is testing genetically modified mosquitoes to deliver vaccinations, funded by the Bill and Melinda Gates Foundation. However, some residents are concerned about the potential risks and lack of scientific investigation. Similar efforts are being made in Houston to combat the Zika virus. Meanwhile, Oxford University has developed a vaccine that could reduce malaria deaths by 70% by 2030. In Fresno, California, a project is releasing a million mosquitoes per week to reduce the population. In Medellin, Colombia, Wolbachia-infected mosquitoes are being released to control diseases like dengue.

In this video, the speaker discusses the challenges of eradicating malaria and the potential use of genetically modified mosquitoes to deliver vaccines. They express concerns about the spread of malaria if the genetic modification fails and question the ethical implications of releasing modified mosquitoes without informed consent. Another speaker highlights the importance of considering climate change and its impact on the geographic range of disease-carrying mosquitoes. They emphasize the need to prevent, prepare for, and respond to emerging pathogens, using the systems and tools developed for COVID-19 as examples. The speaker also mentions the efforts made by countries to strengthen their healthcare systems for various diseases.

CRISPR is a molecular tool that allows for precise genetic editing. Since its introduction in 2012, it has been used to modify various species, including potentially spreading alterations through wild organisms. Malaria is a highly destructive disease, causing the death of 400,000 children annually. Scientists propose using CRISPR to disable or eliminate the mosquito species that transmit malaria, as it is a more effective solution than widespread DDT spraying. Despite potential risks, the severity of malaria outweighs any possible negative consequences, making it a worthwhile endeavor.

We conducted a study in Senegal to see how Ivermectin, given to people for river blindness, affected mosquitoes that transmit malaria. By catching mosquitoes before and after treatment, we found that the drug killed most adult mosquitoes, particularly the ones that transmit malaria. Although the total number of mosquitoes didn't decrease significantly, the drug effectively eliminated the old females responsible for spreading malaria.

Researchers at the Bill Gates Foundation-backed Leiden University Medical Center are developing genetically modified mosquitoes to deliver malaria vaccines. A recent study showed that 8 out of 9 participants who received bites from one type of modified mosquito were protected against malaria, while those in the placebo group received no protection. Despite safety concerns and ethical issues regarding informed consent, the research continues, with plans for larger trials and potential applications for other diseases. Meanwhile, an Australian regulatory body is reviewing an application to release genetically modified mosquitoes to combat dengue fever. The implications of using insects as vaccine carriers raise significant ethical questions, and there are ongoing calls for accountability regarding these experiments.